ebiga-VISION

The vitreous body has a unique protective mechanism against oxidative stress and collagen glycation. However, this mechanism loses efficacy during degeneration. Providing the eye with naturally occurring micronutrients can help reactivate this mechanism, minimising or even preventing collagen fibres from clumping. Discover all about VitroCap®N, including its ingredients, mechanism of action, clinical study data, and expert panel discussions with eye care professionals who have up to 10 years of experience using the product.

Since 2013, extensive scientific studies have investigated important new findings on the effectiveness of VitroCap®N. In five clinical studies, European researchers observed significant improvements in patients with vitreous opacities through the intake of the micronutrients contained in VitroCap®N.

During the 35th International Congress of the German Ophthalmic Surgery Society, ebiga-VISION invited renowned scientists and ophthalmologists to a satellite symposium dedicated to the vitreous body. The presentations and discussions by doctors and researchers summarized the latest findings on vitreous degeneration, its impact on visual performance and quality of life, as well as both surgical and non-surgical treatment options for everyday clinical practice.

Eye floaters can be more than just a minor nuisance – they often affect patients’ daily lives. However, discussing treatment options can be challenging. In an expert discussion, leading specialists shared their clinical experiences and approaches to treating vitreous opacities.